In addition, pharmacological approaches using potent NHE1 inhibitors such as Cariporide or Rimeporide62–64 should be employed to assess their efficacy in stimulating microglial energy metabolism and phagocytosis in post-stroke brain repair. Here, SLC9A1 is linked to Stroke.